| scholarly article | Q13442814 |
| P50 | author | Omar Khan | Q60198867 |
| P2093 | author name string | Yi Zhang | |
| Robert B Innis | |||
| Victor W Pike | |||
| Masahiro Fujita | |||
| Cheryl Morse | |||
| Jussi Hirvonen | |||
| William H Theodore | |||
| William C Kreisl | |||
| Shmuel Appel | |||
| Irene Dustin | |||
| P2860 | cites work | Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function | Q24296269 |
| Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair | Q24644752 | ||
| Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 | ||
| Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers | Q28219401 | ||
| Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker | Q33706576 | ||
| Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation | Q34171364 | ||
| Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation | Q36492494 | ||
| Interictal metabolism and blood flow are uncoupled in temporal lobe cortex of patients with complex partial epilepsy | Q36669892 | ||
| Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis | Q37087330 | ||
| 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy | Q37097688 | ||
| The role of cytokines in the pathophysiology of epilepsy | Q37169936 | ||
| Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain | Q37221310 | ||
| Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity | Q37324183 | ||
| The role of interleukin-1 in seizures and epilepsy: a critical review. | Q37375178 | ||
| Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein | Q37474224 | ||
| A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy | Q40730214 | ||
| Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis | Q42526811 | ||
| Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis | Q43916980 | ||
| Evidence for species differences in 'peripheral' benzodiazepine receptors: an autoradiographic study | Q44914382 | ||
| Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. | Q46590268 | ||
| Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo | Q46860121 | ||
| Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy | Q46954553 | ||
| Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy | Q48108848 | ||
| Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain | Q48190498 | ||
| Complement activation in experimental and human temporal lobe epilepsy | Q48215408 | ||
| "Central" and "peripheral" benzodiazepine receptors: Opposite changes in human epileptogenic tissue | Q48504267 | ||
| [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis | Q57089161 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 234-240 | |
| P577 | publication date | 2012-01-11 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy | |
| P478 | volume | 53 |
| Q26750477 | Advances of Molecular Imaging in Epilepsy |
| Q36709214 | Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? |
| Q36354351 | Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions |
| Q88636391 | Building a database for brain 18 kDa translocator protein imaged using [11C]PBR28 in healthy subjects |
| Q64252972 | Clinical Imaging of Choroid Plexus in Health and in Brain Disorders: A Mini-Review |
| Q38810544 | Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging |
| Q38450069 | Disease modification in epilepsy: from animal models to clinical applications |
| Q37242260 | Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2) |
| Q34457857 | Evidence for brain glial activation in chronic pain patients |
| Q38018121 | Finding a better drug for epilepsy: antiinflammatory targets |
| Q30846878 | Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy |
| Q34789872 | Image derived input function for [18F]-FEPPA: application to quantify translocator protein (18 kDa) in the human brain. |
| Q36567422 | Imaging Brain Inflammation: If We Can See It, Maybe We Can Treat It. |
| Q38673807 | Immunity and Inflammation in Epilepsy |
| Q90288735 | In Vivo Imaging of Neuroinflammatory Targets in Treatment-Resistant Epilepsy |
| Q28274003 | In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease |
| Q34680915 | In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence |
| Q97599625 | Innovations in the Neurosurgical Management of Epilepsy |
| Q37639944 | Investigation of an F-18 oxytocin receptor selective ligand via PET imaging |
| Q38259759 | Maternal immune activation and abnormal brain development across CNS disorders. |
| Q36634134 | Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy |
| Q87933862 | Neuroimaging of epilepsy |
| Q46360384 | Neuroinflammation imaging markers for epileptogenesis. |
| Q37584734 | Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein |
| Q50117953 | Neuroinflammation of the spinal cord and nerve roots in chronic radicular pain patients |
| Q91530192 | Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy |
| Q39523354 | PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. |
| Q100960869 | PET imaging of neuroinflammation in neurological disorders |
| Q36900751 | PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide |
| Q34994500 | PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema |
| Q90625637 | Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies |
| Q35634593 | Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation |
| Q37184087 | Propofol decreases in vivo binding of 11C-PBR28 to translocator protein (18 kDa) in the human brain. |
| Q33632167 | Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [11C]-( R)-PK11195 PET and MRI. |
| Q47736555 | Recent Advances in Radiotracer Imaging Hold Potential for Future Refined Evaluation of Epilepsy in Veterinary Neurology |
| Q47291761 | Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases |
| Q27009518 | Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches |
| Q64123478 | The expression of inflammatory markers and their potential influence on efflux transporters in drug-resistant mesial temporal lobe epilepsy tissue |
| Q42327985 | Transient and chronic seizure-induced inflammation in human focal epilepsy |
| Q39018707 | WONOEP appraisal: Imaging biomarkers in epilepsy |
| Q89791792 | [11C]PBR28 MR-PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder |
| Q38772065 | [18F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease |
| Q40335715 | miR-146a negatively regulates the induction of proinflammatory cytokines in response to Japanese encephalitis virus infection in microglial cells |
Search more.